LEQEMBI Alzheimer’s Treatment Gets FDA Go Ahead
Phase 2 data showing a reduction in amyloid-beta plaques in early Alzheimer's patients is good enough for FDA to give it temporary approval under their Accelerated Approval pathway.
More reads
Fast Radio Bursts: Solving One Of The Universe's Mysteries
One of the most baffling puzzles of modern astrophysics is the nature of Fast Radio Bursts, which were discovered in 2007. These are seemingly rare, extremely bright flashes of light with radio…
The Plot Of The Week - CMS Searches For Higgs Decays To Charm Quarks
While you and I may have been lagging behind a bit as of late, excused by a particularly hot July, the CMS collaboration has kept grinding its data, producing exquisite new results from the large…
The Feel Good Fallacy Of Elite Philanthrophy
MacKenzie Scott does not give Science 2.0 any money. I wish she did. For a minute fraction of her $57 billion we could increase the science literacy for Americans quite a lot.